Cisplatin, Carboplatin, Oxaliplatin
10,122 views
Oncology Pharm
- Bleomycin
- Dactinomycin, Actinomycin D
- Doxorubicin, Daunorubicin
- Azathioprine, 6-MP
- Cladribine
- Cytarabine
- Busulfan
- Cyclophosphamide, Ifosfamide
- Nitrosoureas
- Paclitaxel
- Vincristine, Vinblastine
- Cisplatin, Carboplatin, Oxaliplatin
- Etoposide, Teniposide
- Irinotecan, Topotecan
- Bevacizumab
- Erlotinib
- Cetuximab, Panitumumab
- Imatinib, Dasatinib
- Rituximab
- Bortezomib, Carfilzomib
- Trastuzumab
- Dabrafenib, Vemurafenib
- Raloxifene and Tamoxifen
- Hydroxyurea
- Procarbazine
Summary
Cisplatin, carboplatin, and oxaliplatin are all platinum-containing drugs that function as chemotherapeutics by crosslinking DNA via their platinum atoms. They are useful in the treatment of solid tumors, but patients taking these drugs can experience nephrotoxicity, including Fanconi syndrome, which can be prevented with the administration of amifostine. Other side effects to note include ototoxicity and peripheral neuropathy.
Key Points
- Platinum Analogs (cisplatin, carboplatin, oxaliplatin)
- Mechanism
- Crosslinks DNA
- Clinical use
- Solid tumors
- Testicular cancer
- Bladder cancer
- Ovarian cancer
- Lung cancer
- Solid tumors
- Adverse effects
- Nephrotoxicity
- Including acute tubular necrosis and Fanconi syndrome
- Can be prevented with amifostine and chloride (saline) diuresis
- Amifostine is a free radical scavenger
- Can be prevented with amifostine and chloride (saline) diuresis
- Including acute tubular necrosis and Fanconi syndrome
- Ototoxicity
- Can cause sensorineural hearing loss and deafness
- Peripheral neuropathy
- Nephrotoxicity
- Mechanism